La Grace Bio is a circular biotechnology company developing process-defined biological conversion systems that transform agricultural and food-chain biomass into standardized, high-value bio-based materials.
The platform converts underutilized biomass, including whole Citrullus lanatus (watermelon) residues, into reproducible metabolite and lipid assemblies using low-energy, zero-added-water bioconversion methods. This approach enables the recovery of functional biological materials while reducing organic waste disposal and associated greenhouse gas emissions.
Unlike conventional extraction systems that rely on solvents, high water consumption, or variable raw materials, La Grace Bio focuses on controlling biological transformation pathways to produce consistent outputs suitable for industrial applications. These materials can be used in sectors such as sustainable cosmetics, biomaterials, and functional ingredient systems.
The company’s innovation contributes to circular economy implementation by converting waste streams into valuable resources, reducing landfill dependency, lowering methane emissions from organic waste, and supporting decentralized production models near biomass sources.
La Grace Bio is currently advancing pilot-scale validation and life-cycle assessment work in collaboration with research and institutional partners, with the long-term objective of enabling scalable distributed biological manufacturing systems.